Skip to Content


In the US, Xenazine (tetrabenazine systemic) is a member of the drug class VMAT2 inhibitors and is used to treat Huntington's Disease.

US matches:

Ingredient matches for Xenazine


Tetrabenazine is reported as an ingredient of Xenazine in the following countries:

  • France
  • Greece
  • Israel
  • Malta
  • Netherlands
  • New Zealand
  • Poland
  • Switzerland
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.